Gain Therapeutics Q3 Loss Narrows
(RTTNews) - Gain Therapeutics, Inc. (GANX) on Tuesday reported a narrower net loss for the third quarter of 2026 compared with the same period in 2025, as reduced research and development and general and administrative expenses lowered overall operating costs.